Carbutamide Explained
Carbutamide (brand name Glucidoral) is an anti-diabetic drug of the sulfonylurea class, developed by Servier.
It is classified as first-generation.[1]
It was patented in 1953 and approved for medical use in 1956.[2]
See also
Notes and References
- Ballagi-Pordány G, Köszeghy A, Koltai MZ, Aranyi Z, Pogátsa G . Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds . Diabetes Research and Clinical Practice . 8 . 2 . 109–114 . January 1990 . 2106423 . 10.1016/0168-8227(90)90020-T .
- Book: Fischer J, Ganellin CR . Analogue-based Drug Discovery . 2006 . John Wiley & Sons . 9783527607495 . 449 . en.
